Published • loading... • Updated
Recent Research Analysts’ Ratings Updates for Vaxcyte (PCVX)
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Recent Research Analysts’ Ratings Updates for Vaxcyte (PCVX)
Vaxcyte (NASDAQ: PCVX) has recently received a number of price target changes and ratings updates: 10/5/2026 – Vaxcyte had its price target raised by Guggenheim from $116.00 to $125.00. They now have a “buy” rating on the stock. 10/5/2026 – Vaxcyte had its “buy” rating reaffirmed by BTIG Research. They now have a $89.00 price […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
